Literature DB >> 18687653

More on microembolism and foam sclerotherapy.

Janet E Rush, David D I Wright.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18687653     DOI: 10.1056/NEJMc080996

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Acronym madness - part 2.

Authors:  E C Abbott
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

2.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-17       Impact factor: 3.210

3.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-11       Impact factor: 3.210

Review 4.  Polidocanol for endovenous microfoam sclerosant therapy.

Authors:  David M Eckmann
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

5.  Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Authors:  Dario Carugo; Dyan N Ankrett; Xuefeng Zhao; Xunli Zhang; Martyn Hill; Vincent O'Byrne; James Hoad; Mehreen Arif; David D I Wright; Andrew L Lewis
Journal:  Phlebology       Date:  2015-06-01       Impact factor: 1.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.